IL246417B - Genetic markers related to suicide risk and methods of using them - Google Patents
Genetic markers related to suicide risk and methods of using themInfo
- Publication number
- IL246417B IL246417B IL246417A IL24641716A IL246417B IL 246417 B IL246417 B IL 246417B IL 246417 A IL246417 A IL 246417A IL 24641716 A IL24641716 A IL 24641716A IL 246417 B IL246417 B IL 246417B
- Authority
- IL
- Israel
- Prior art keywords
- methods
- genetic markers
- markers associated
- suicide risk
- suicide
- Prior art date
Links
- 206010010144 Completed suicide Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Primary Health Care (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361920332P | 2013-12-23 | 2013-12-23 | |
| PCT/CA2014/051257 WO2015095967A1 (en) | 2013-12-23 | 2014-12-23 | Genetic markers associated with suicide risk and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL246417A0 IL246417A0 (en) | 2016-08-31 |
| IL246417B true IL246417B (en) | 2020-08-31 |
Family
ID=53477254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL246417A IL246417B (en) | 2013-12-23 | 2016-06-23 | Genetic markers related to suicide risk and methods of using them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10435748B2 (https=) |
| EP (1) | EP3087203B1 (https=) |
| JP (1) | JP6679486B2 (https=) |
| KR (1) | KR20160111925A (https=) |
| CN (1) | CN106062213A (https=) |
| AU (1) | AU2014373588B2 (https=) |
| CA (1) | CA2934815C (https=) |
| IL (1) | IL246417B (https=) |
| SG (1) | SG11201605150YA (https=) |
| WO (1) | WO2015095967A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2891830A1 (en) | 2015-05-15 | 2016-11-15 | Centre For Addiction And Mental Health | Genetic markers for suicide risk and related methods |
| US20170312289A1 (en) * | 2016-04-29 | 2017-11-02 | Supernus Pharmaceuticals, Inc. | Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression |
| CN108531569B (zh) * | 2017-03-03 | 2021-05-07 | 上海伯豪医学检验所有限公司 | 用于强迫症与精神分裂症、抑郁症甄别的基因标志物及其应用 |
| CN108148905A (zh) * | 2018-02-13 | 2018-06-12 | 广州市番禺区中心医院(广州市番禺区人民医院、广州市番禺区心血管疾病研究所) | 一段可作为抑郁症标记物的序列 |
| EP3975190A4 (en) * | 2019-05-23 | 2023-05-03 | Ulsan National Institute of Science and Technology (UNIST) | METHOD OF DISCOVERING A MARKER FOR PREDICTING RISK OF DEPRESSION OR SUICIDE USING MULTIOMICS ANALYSIS, MARKERS FOR PREDICTING RISK OF DEPRESSION OR SUICIDE AND METHODS OF PREDICTING RISK OF DEPRESSION OR SUICIDE USING MULTIOMICS ANALYSIS |
| WO2024215722A1 (en) * | 2023-04-10 | 2024-10-17 | Board Of Regents, The University Of Texas System | Methods and compositions for diagnosing and treating depression and suicide risk |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USH2191H1 (en) | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| US7361468B2 (en) | 2004-07-02 | 2008-04-22 | Affymetrix, Inc. | Methods for genotyping polymorphisms in humans |
| EP2166112B1 (en) * | 2008-09-18 | 2013-06-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Means and methods for diagnosing predisposition for treatment emergent suicidal ideation |
| CA2736936A1 (en) * | 2008-09-18 | 2010-03-25 | Andreas Menke | Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi) |
| KR101249635B1 (ko) * | 2010-10-13 | 2013-04-01 | 서울대학교산학협력단 | 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트 |
-
2014
- 2014-12-23 JP JP2016542129A patent/JP6679486B2/ja active Active
- 2014-12-23 CA CA2934815A patent/CA2934815C/en active Active
- 2014-12-23 CN CN201480076117.6A patent/CN106062213A/zh active Pending
- 2014-12-23 WO PCT/CA2014/051257 patent/WO2015095967A1/en not_active Ceased
- 2014-12-23 KR KR1020167019492A patent/KR20160111925A/ko not_active Withdrawn
- 2014-12-23 US US15/107,437 patent/US10435748B2/en active Active
- 2014-12-23 EP EP14873830.5A patent/EP3087203B1/en not_active Not-in-force
- 2014-12-23 SG SG11201605150YA patent/SG11201605150YA/en unknown
- 2014-12-23 AU AU2014373588A patent/AU2014373588B2/en not_active Ceased
-
2016
- 2016-06-23 IL IL246417A patent/IL246417B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP3087203A4 (en) | 2017-09-20 |
| US20170002412A1 (en) | 2017-01-05 |
| JP2017503493A (ja) | 2017-02-02 |
| CA2934815C (en) | 2022-01-04 |
| IL246417A0 (en) | 2016-08-31 |
| US10435748B2 (en) | 2019-10-08 |
| CA2934815A1 (en) | 2015-07-02 |
| SG11201605150YA (en) | 2016-07-28 |
| CN106062213A (zh) | 2016-10-26 |
| EP3087203A1 (en) | 2016-11-02 |
| EP3087203B1 (en) | 2019-09-11 |
| AU2014373588A1 (en) | 2016-07-21 |
| JP6679486B2 (ja) | 2020-04-15 |
| WO2015095967A1 (en) | 2015-07-02 |
| AU2014373588B2 (en) | 2021-04-01 |
| KR20160111925A (ko) | 2016-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246223A0 (en) | fcrn antagonists and their use | |
| IL244665A0 (en) | Conjugates of chlorotoxin and methods of using them | |
| EP2943202A4 (en) | IRAQ INHIBITORS AND USES THEREOF | |
| IL246221B (en) | Endazoles and their uses | |
| IL244296A0 (en) | Cell-permeable conjugates and methods of using them | |
| IL245839B (en) | Inhibitors of rna polymerase i and use of preparations containing them for treatment | |
| IL253160A0 (en) | Cancer markers and methods of using them | |
| AP2015008835A0 (en) | Biocidal systems and methods of use | |
| AP2016009207A0 (en) | Genetic markers and uses therefor | |
| SG11201504771RA (en) | Host cells and methods of use | |
| IL244214B (en) | Thienopiperidine derivative and its use | |
| PT2967044T (pt) | Composição herbicida e seu método de uso | |
| IL246417B (en) | Genetic markers related to suicide risk and methods of using them | |
| IL243433B (en) | Titanium bibory layers and their production | |
| EP3027182A4 (en) | Novel copper-cysteamine and methods of use | |
| PL2994150T3 (pl) | Probiotyki i sposoby zastosowania | |
| IL245272A0 (en) | pif-transfected cells and methods of use | |
| GB201309178D0 (en) | Enzyme and uses thereof | |
| IL245159B (en) | Genetic markers of an antipsychotic drug for weight gain and methods of using them | |
| SG11201601263WA (en) | Recombinant microorganisms and methods of use thereof | |
| WO2014202624A9 (en) | Rasamsonia gene and use thereof | |
| GB201303476D0 (en) | Agrochemical composition and method of use thereof | |
| ZA201600203B (en) | Axmi422 toxin gene and methods for its use | |
| ZA201600204B (en) | Axmi440 toxin gene and methods for its use | |
| AU2014903514A0 (en) | Markers of Disease Susceptibility and Onset and Uses Therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |